Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04746924
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-31
First Post:
2021-02-05
Brief Title:
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
Sponsor:
BeiGene
Organization:
BeiGene
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-05
First Submit QC Date:
February 5 2021
Study First Post Date:
2021-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-11
Last Update Post Date:
2024-05-31
Last Update Post Date Type:
ACTUAL